This 2010 report describes the experiences of grantees who participated in the Robert Wood Johnson Foundation’s State/Provider Partnerships for Quality Addiction Care program between 2005 and 2010. It describes lessons learned by grantees as they established medication assisted treatment programs in their organizations.
This guide provides information providers need to implement a medication assisted treatment (MAT) program for patients with opioid use disorder in their community.
A companion document to New Hampshire’s guidance on creating community-based medication assisted treatment (MAT) services for opioid use disorder, this quality planning tool guides staff through the steps necessary to develop and implement an MAT program.
This one page information piece challenging the myths around medication assisted treatment for opioid use disorder was created by the National Council on Behavioral Health and is directed at physicians and other health care providers.
The National Alliance for Recovery Residences published this guide for operators of recovery housing on how to incorporated medication assisted treatment for opioid use disorder into their programs.
The National Alliance for Recovery Residences published this guide to supporting the use of medication assisted treatment (MAT) in recovery housing programs in 2019. Directed at state and local policy makers, the report describes the challenges of adding MAT to recovery residence programs and proposes strategies for expanding recovery housing overall and specifically housing programs that can support residents on MAT.
This 2014 guideline from the Michigan Department of Community Health provides an overview of addiction and opioid use disorder with information specifically about medication assisted treatment.
The state of Massachusetts passed legislation in 2018 requiring acute care hospitals to develop programs to initiate medication assisted treatment (MAT) for patients with opioid use disorder (OUD) seen in the emergency department. These guidelines, developed by the Massachusetts Hospital Association and state College of Emergency Physicians, offer clinical and operational recommendations for hospitals when implementing this state policy.
This patient education publication describes the risks of taking benzodiazepine medications while also being treated for opioid use disorder with medication assisted treatment.
This 2018 report from the Institute for Clinical and Economic Review compared the evidence for effectiveness and value of new extended-release medications for opioid use disorder (two buprenorphine injections, one buprenorphine implant, and naltrexone injection).